[Solved]: RD is a 58-year-old man with newly diagnosed…

RD is a 58-year-old man with newly diagnosed “double-hit” (MYC and BCL2 rearrangements) DLBCL, stage IV, ECOG performance status 1. According to NCCN Guidelines version 2.2025, which induction regimen is a commonly used due to non-randomized data suggesting improved outcomes? A. R-CHOP B. Dose-adjusted R-EPOCH C. pola-R-CHP D. R-CVP (rituximab, cyclophosphamide, vincristine, and prednisolone)